ExchangeDEX+

Buy Crypto Markets Spot FuturesGOLD Earn Event Center

Commodity Zero-Fee Gala

BioNexus Gene Lab Corp. (BGLC)

NASDAQ

$2.05

$--

(0.00%)

BioNexus Gene Lab Corp. (BGLC) Live Price Chart

Page last updated: 2026-02-12 18:33:00

Key Market Data

Market Cap	$4.85M
Open	$1.92
High	$267.60
Low	$1.90
Previous Close	$1.95
Price Change	--
Percentage Change	0.00%
Volume	5K

BioNexus Gene Lab Corp. (BGLC) Stock Price Today

BioNexus Gene Lab Corp. (BGLC) is currently trading at $2.05 as of 2026-02-12 18:33:00, reflecting a 0.00% move ($-0.00) from the previous close.

In the short term, the stock has returned -4,547.87% over the past four weeks. Over the last 12 months, BioNexus Gene Lab Corp. has recorded a -41.68% price change, indicating a weak performance relative to the broader market.

BioNexus Gene Lab Corp. (BGLC) 7-Day Stock Price Changes

Over the past seven days, BioNexus Gene Lab Corp. has traded within a short-term range shaped by market sentiment in the SERVICES-MEDICAL LABORATORIES sector. During this period, the stock moved from its previous closing price of $2.05 to the latest recorded price of $2.05, reflecting an intraday change of 0.00%. Daily movements highlight shifts in trading volume (5,023), investor positioning, and reactions to macroeconomic updates.

From a momentum standpoint, BGLC has delivered a -4,547.87% return over the past month and a -41.68% change in the last 12 months, indicating a weak trend relative to its broader sector peers.

How to Buy BioNexus Gene Lab Corp. (BGLC)

You can buy and trade BGLC on MEXC in three simple steps:

Step 1: Create and Verify Your MEXC Account

Sign up on MEXC and complete the required identity verification (KYC). This ensures full access to trading features and secure funding options.

Step 2: Deposit Funds Into Your Account

Choose your preferred payment method to add USDT or other supported assets to your MEXC wallet. Depositing crypto is the fastest way to get started.

Step 3: Search for BGLC and Execute Your Trade

Open the trading page, enter BGLC in the search bar, select the amount of BGLC you would like to purchase. Place a market order for instant execution or a limit order to buy at your target price.

What is BioNexus Gene Lab Corp. (BGLC)?

BioNexus Gene Lab Corp, through its wholly owned subsidiary, focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic industries in the Southeast Asia region. These countries include Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. In addition, the Company is in the business of developing and providing safe, effective, and non-invasive liquid biopsy tests for the early detection of biomarkers that it believes are linked to diseases to minimize treatment costs and improve patient management. Its non-invasive blood tests provide analysis of changes in RNA to detect the potential risk of different diseases.

BioNexus Gene Lab Corp. Information

Industry	SERVICES-MEDICAL LABORATORIES
Employees	1
Sector	SERVICES-MEDICAL LABORATORIES
Company Website	https://www.bionexusgenelab.com

Frequently Asked Questions (FAQ)

1.What is the current share price of BioNexus Gene Lab Corp.?

The latest trading price for BioNexus Gene Lab Corp. (Common Stock) is $ 2.05, compared with a previous closing price of $ 1.95. That means the stock has moved 0.00% so far today. Intraday price updates and recent trading activity for BGLC can be tracked on the live chart and quote section on this page.

2.Is BioNexus Gene Lab Corp. stock going up or down?

Looking at recent performances, BGLC has returned -4,547.87% over the past month, -61.47% over the last six months and -41.68% over the past year. These figures capture share-price changes only, not the impact of dividends. Together they describe weak price momentum for BioNexus Gene Lab Corp. stock, but keep in mind that past returns do not guarantee future results.

3.Where does BGLC currently sit relative to its 52-week high and low?

In the most recent 52-week period, BioNexus Gene Lab Corp. has traded between a low of $ 1.90 and a high of $ 15.60. This 52-week range helps show where today's share price sits relative to its recent highs and lows, and is often used by investors to judge stock volatility, potential support and resistance levels, and whether BGLC is currently nearer the top or the bottom of its one-year trading band.

4.How is BioNexus Gene Lab Corp. classified by sector and industry?

BioNexus Gene Lab Corp. is classified in the SERVICES-MEDICAL LABORATORIES sector. In practice, this means BioNexus Gene Lab Corp. is grouped with other companies that serve similar end-markets and operate under comparable competitive and regulatory conditions. For investors, knowing BGLC’s sector helps with portfolio diversification, peer comparisons, and understanding how broader trends affecting the SERVICES-MEDICAL LABORATORIES sector could influence BioNexus Gene Lab Corp.’s performance.

5.Where is BioNexus Gene Lab Corp. listed and how large is it by market value?

BioNexus Gene Lab Corp. is listed on the NASDAQ stock exchange in United States. Based on a market capitalization of $ 4.85M, the company is classified as a Small-cap stock. Market cap gives a quick sense of BioNexus Gene Lab Corp.'s size and importance in the equity market and is often used by investors and index providers when constructing portfolios or benchmarks.

6.What does BGLC's EPS tell investors about its profitability?

Trailing-twelve-month EPS of $ -0.97 summarises how much profit BioNexus Gene Lab Corp. has generated per share over the last year. Rising EPS over time can signal improving profitability or effective share repurchases, while flat or declining EPS may point to slower growth or margin pressure. EPS is a key input into valuation metrics such as P/E and is often monitored closely around earnings announcements.

7.How can I track BioNexus Gene Lab Corp.'s financial performance over time?

To follow BioNexus Gene Lab Corp.'s financial performance, investors typically review its quarterly and annual reports, which include detailed income statements, balance sheets and cash-flow statements. Combining these filings with key market data shown on this page—such as share price trends, P/E and dividend yield—provides a more complete view of how BGLC is performing and how the market is responding.

8.When is BioNexus Gene Lab Corp. expected to report earnings?

BioNexus Gene Lab Corp.'s next scheduled earnings release is currently expected on -- (the date may be updated by the company). Earnings announcements often act as important catalysts for BGLC, as they provide updated information on revenue, profitability and management's outlook.

9.What usually comes out in BioNexus Gene Lab Corp.'s earnings reports?

BioNexus Gene Lab Corp.'s earnings reports typically include headline figures such as revenue, net income and EPS, along with commentary on segment performance, margins, cash flow and guidance for future periods. Investors compare these results with market expectations and prior periods to assess whether BGLC is meeting, beating or missing expectations.

10.How can I stay informed about BioNexus Gene Lab Corp.'s results and guidance?

You can stay up to date on BioNexus Gene Lab Corp. by reviewing its quarterly earnings releases, listening to or reading transcripts of earnings calls, and following company news and filings. Pairing this fundamental information with the price and return data for BGLC on this page helps you see how new information is being reflected in the stock.

11.Does BioNexus Gene Lab Corp. pay a regular cash dividend to its shareholders?

BioNexus Gene Lab Corp. Non-paying. Based on the latest information, the stock has an indicated annual cash dividend of -- per share and a current dividend yield of 0 at the recent share price. Dividends are typically paid --, although the board can change the dividend policy at any time. Income-focused investors often monitor BGLC's dividend level, payment frequency and any announcements about future dividends when assessing the stock's appeal as a dividend-paying investment.

12.What are the current dividend yield and dividend payout ratio for BGLC?

Based on the latest earnings data, BGLC has a dividend yield of 0 and a dividend payout ratio of 0. The dividend yield shows how much cash return an investor receives from dividends each year relative to the current share price, helping assess whether BioNexus Gene Lab Corp. is an attractive income stock. The dividend payout ratio measures what percentage of earnings BioNexus Gene Lab Corp. distributes to shareholders as dividends versus how much it retains to reinvest in the business, which is an important indicator of dividend sustainability and room for future dividend growth.

13.What kind of business is BioNexus Gene Lab Corp.?

BioNexus Gene Lab Corp. is a publicly traded company in the SERVICES-MEDICAL LABORATORIES industry within the SERVICES-MEDICAL LABORATORIES sector. It generates revenue from products and services related to this core business area, and investors can find a detailed description of its operations, strategy and geographic exposure in the company's annual report and other regulatory filings.

14.How is BGLC valued in terms of P/E ratio and EPS?

BioNexus Gene Lab Corp. currently trades at a price-to-earnings (P/E) ratio of --, based on trailing-twelve-month earnings per share (EPS) of $ -0.97. P/E is calculated by dividing the share price by EPS and shows how much investors are paying today for each unit of BioNexus Gene Lab Corp.'s earnings. Comparing BGLC's P/E and EPS to those of other SERVICES-MEDICAL LABORATORIES companies can help investors judge whether its valuation looks rich or attractive.

Explore More US Stocks

Stocks in the Same Sector

Browse other US stocks in the same sector as BioNexus Gene Lab Corp.

The Walt Disney Company

DIS

Largest Market Cap

See US stocks with the highest market capitalization

Most Actively Traded

Discover today's most actively traded US stocks

Financial Institutions Inc.

FISI

Greenwave Technology Solutions, Inc.

GWAV

Global Water Resources, Inc.

GWRS

Horizon Bancorp, Inc.

HBNC

ICF International, Inc.

ICFI

Top Gainers

Browse today's leading gainers in the US stock market

IPG Photonics Corporation

IPGP

Jiuzi Holdings, Inc.

JZXN

Top 5 Cryptocurrencies

Explore the cryptocurrencies with the highest market capitalization

BTC

ETH

SOL

Disclaimer

The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.

BGLC-to-USD Calculator

Amount

BGLC

USD

1 BGLC = 2.04 USD